Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Raises $1.2M in Private Financing

NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen said in a regulatory document that it has raised more than $1.2 million toward a targeted $1.5 million private financing round. 

Through a spokesperson, the Gaithersburg, Md.-based firm declined to comment. OpGen said in a document filed with the US Securities and Exchange Commission that there were nine investors in the round, but did not identify them. It also did not say how the funds would be used. 

It said that the types of securities offered were debt; an option, warrant, or other right to acquire another security; and security to be acquired upon the exercise of an option, warrant, or other right to secure security. 

OpGen said last July that it raised $1.1 million of a targeted $1.5 million financing round.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.